⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABOS News
Acumen Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
ABOS
Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Highlights
globenewswire.com
ABOS
Acumen Pharmaceuticals to Present Preliminary Baseline Characteristics and Data on Care Experiences and Participation in Phase 2 ALTITUDE-AD Trial at the 19th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
globenewswire.com
ABOS
Acumen Pharmaceuticals to Report Third Quarter Financial Results on October 26, 2026
globenewswire.com
ABOS
Form 8-K
sec.gov
ABOS
Acumen Pharmaceuticals to Hold Virtual Investor Day on September 16, 2026
globenewswire.com
ABOS
Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences
globenewswire.com
ABOS
Form 8-K
sec.gov
ABOS
Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights
globenewswire.com
ABOS
Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026
globenewswire.com
ABOS